llpete Posted January 21, 2017 Share Posted January 21, 2017 I was diagnosed in 2012 and completed treatment in dec of 2012. Test have been clear until dec 2016. My Oncologist said that I can start taking Crizontinib but that I also qualify for a Clinical study. A phase 3 Multi-center Open label study of Brigatinib versus Crizotinib in Patients with ALK positive Advance Lung Cancer. Has anyone participating or had participated in this study ? Sent from my iPad using Tapatalk Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.